The aim of this work is to investigate the use of bone morphogenetic proteins (rhBMP-2, rhBMP-4) alone or in combination with cells delivered in a calcium alginate gel for the treatment of osteochondral defects. For this purpose, alginate gels were prepared mixing a 2% sodium alginate solution and a 200mM calcium chloride solution (1:1). Osteochondral defects were created (4mm wide, 5mm deep) in the internal femoral condyle of rabbit knee and gels were directly formed into the defects. 3 months after surgery samples were harvested, gross morphology was documented and histological appearance was evaluated. The performed histological observations revealed subchondral bone regeneration in rhBMP-2 samples and moderate hyaline cartilage regeneration in rhBMP-4 samples. Thus, results indicate that alginate gel may serve as an appropriate delivery vehicle for rhBMP-2, rhBMP-4 and stromal cells. With this carrier material, differential behaviour between the evaluated proteins was observed. rhBMP-2 shows better restoration of subchondral bone in contrast to the superior efficiency of rhBMP-4 for hyaline cartilage repair.
Introduction
A variety of clinical procedures have been developed to repair articular cartilage defects, but success has been limited. Restoration of articular cartilage continues to pose a difficult problem to the orthopaedic surgeon because a treatment that enables full restoration of injured articular cartilage to its original state is not yet known . Ability of adult cartilage to regenerate is limited due to its avascularity, the poor mitotic capacity of chondrocytes and the absence of stem cells in this tissue (Buckwalter et al., 1997) . Injuries of the joint surface that do not penetrate the subchondral bone have only a minimal healing response and may progress to post-traumatic osteoarthrosis (O'Driscoll et al., 2001) . Defects that extend into the subchondral bone allow for formation of a fibrous or fibrocartilaginous tissue with biochemical and biomechanical properties different from hyaline cartilage that undergoes premature degeneration (Marco et al., 1992) . Tissue engineering based on cell and growth factors is one of the most promising new approaches by which to repair various tissues, including articular cartilage (Nesic et al., 2006) .
Many different types of biomaterials have been tested in vitro, as well as in experimental animals and in human patients, in order to facilitate or promote the repair of cartilage lesions. Scaffolds are used not only as passive material, allowing the surrounding tissue ingrowth and participate in the repair procedure, but also with active role, as carriers for both cells and growth factors (Grande et al., 1997; Lee et al., 2007; Malafaya et al., 2007; Melrose et al., 2008; Sohier et al., 2008; Abarrategi et al., 2010) . The summary of all this experience is that the choice of the material is critical for the success of tissue engineering approaches in cartilage repair procedures. This work employed alginate as growth factor and cell carrier. Alginates are naturally derived polysaccharides that have been used extensively in cell and/or growth factor encapsulation, cell transplantation, and tissue engineering applications (Diduch et al., 2000; Mierisch et al., 2003; Chawla et al., 2007; Hannouche et al., 2007) . Alginates are composed of Dmannuronic acid and L-guluronic acid. Divalent cations such as calcium create ionic interchain bridges of adjacent alginate molecules, which cause gelling of an aqueous alginate solution.
Cells are widely used in osteochondral approaches due to their role in the new tissue formation. The variety of (Grande et al., 1989; Raghunath et al., 2005) . Administration of growth factors that can enhance cartilage healing is another important facet of cartilage repair. Local application of growth factors is preferred to avoid systemic toxicity, but the concentration and rate of release of the growth factor at the site of injury has been difficult to determine and to control. Several growth factors, including transforming growth factor (TGF), bone morphogenetic proteins (BMPs), insulin-like growth factor 1, and basic fibroblast growth factor, can improve chondrocyte proliferation and extracellular matrix (ECM) synthesis in vitro and in vivo (van den Berg et al., 2001; Van der Kraan et al., 2002) . Studies performed in vitro and in vivo have led to the identification of rhBMP-2 and rhBMP-4 as promising candidates for the promotion of chondrogenesis. Both of them have been shown to play a role in chondrocyte differentiation and matrix maturation (Luyten et al., 1994; Miljkovic et al., 2008) .
IN VIVO COMPARISON OF THE EFFECTS OF RHBMP-2 AND RHBMP-4 IN OSTEOCHONDRAL TISSUE REGENERATION
The aim of the present work is to investigate the use of these proteins (rhBMP-2, rhBMP-4), alone or in combination with cells trapped in calcium alginate gel for the treatment of osteochondral defects.
Materials and Methods
Bone morphogenetic proteins (rhBMP-2 and rhBMP-4) E. coli produced recombinant human rhBMP-2 (rhBMP-2) and rhBMP-4 (rhBMP-4) were generously supplied by Noricum S.L. (Tres Cantos, Spain). The biological activity of both rhBMP-2 and rhBMP-4 was tested in vitro measuring the Alkaline Phosphatase activity (ALP) induced on C2C12 cells as previously described (Abarrategi et al., 2009) .
Cell Cultures
Rabbit stromal cells were obtained from femur bone marrow as previously described (Tsutsumi et al., 2001) . Briefly, both ends of the femurs of each rabbit were removed at the level of the epiphysis, and the marrow plugs were flushed out and homogenised using a cell culture medium (DMEM in high glucose, containing 15% foetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/mL streptomycin and 2,5 μg/mL amphotericin). Cells were placed in tissue culture flasks. The medium was changed after the first 48 h and subsequently every three days. After 10-14 days, a confluent cell monolayer was obtained. Subsequent routine passaging was done at 80% of confluence and at an initial cellular density of 5000 cells/ cm 2 . The culture medium was changed every two to three days.
Preparation of alginate gels
For the preparation of alginate gels we employed a 2% sodium alginate solution (Sigma, St. Louis, MO, USA) in phosphate buffered saline (PBS). We also employed 200 mM calcium chloride solution (Sigma®) in acetic acid 50 mM. Both solutions were mixed 1:1 and after 30 seconds, the alginate gel was obtained. When used: Stromal cells were resuspended in the alginate solution prior to gelation; BMPs were firstly solubilised in acetic acid (AcH) 50 mM (pH 3.5) and later mixed with the alginate solution, prior to gelation.
Cellular assays
Cells obtained in routine passaging were centrifuged and washed twice with PBS. The final cell pellet was resuspended in an alginate solution (2% alginate in PBS). 50 μL of this alginate solution, containing 1x10 6 cells, were gelled directly into each well of a 48 well tissue culture plate, by the addition of 50 μL of a calcium chloride solution (200 mM in AcH 50 mM). Alginate solutions with rhBMP-2 and rhBMP-4 (15 μg / 50 μL) were also assayed. After gelling, the remaining medium was removed and cell culture medium was added.
Cell viability was checked with LIVE/DEAD®, Viability/Cytotoxicity assay (Molecular Probes, Eugene, OR, USA). This assay determines the intracellular esterase activity and plasma membrane integrity. This assay uses the green fluorescent polyanionic dye calcein, which is retained within live cells. It also uses the red fluorescent ethidium homodimer, which can enter cells only through damaged membranes to bind to nucleic acids but is excluded by the intact plasma membrane of live cells. Briefly, Cell culture medium was removed and 100 μL of PBS supplemented with 2 μM Calcein AM and 2 μM Ethidium homodimer were added. Plates were stored 1 h in the dark at 37ºC. Then, materials were transferred to microscope slides and fluorescence was observed in a Fluorescence microscope (Olympus BX51; Olympus, Tokyo, Japan). Assays were performed in independent samples at 4 and 7 culture days.
Cell viability was quantified by alamarBlue® assay (Biosource, Camarillo, CA, USA). The active ingredient of this assay (resazurin) is a nontoxic, cell permeable compound that is blue in colour and virtually nonfluorescent. Upon entering cells, resazurin is reduced to resorufin, which is also cell permeable and produces very bright red fluorescence, generating a quantitative measure of viability. Briefly, cell culture medium was removed. 400 μL of fresh culture medium and 40 μL of alamar blue reagent were added to each well. After incubation (1 h at 37ºC and 5% CO 2 ) medium was transferred to new plate and fluorescence was measured (excitation wavelength 540 nm, emission wavelength 590 nm) (Biotek FL-600; Biotek, Arcugnano Vicenza, Italy). Blank readouts were subtracted from measures. Assays were performed in independent samples and in a time course.
Animals and surgical procedure
Surgical procedures and animal care were performed in compliance with the regulations of the National Institutes Y Lópiz-Morales et al.
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of Health of the European Union States Public Health Service with the approval of the institution´s Animal Care and Use Committee, and they were done under supervision of a licensed veterinarian. 26 New Zealand White (NZW) rabbits housed individually in cages were used for the study with an initial weight between 2.3-2.9 Kg and about 5 months old. Animals were anaesthetised with a mixture of xylazine (Rompum ®) (3 mg/kg), ketamine (Ketolar ®) (80 mg/kg) and atropine sulphate (Atropina Braun ®) (1 mg/kg) delivered by intramuscular injection. Before surgical procedure, knees were shaved, prepared and draped in a sterile fashion. In each knee the following procedure was used: A medial parapatellar incision was made in each knee and the patella was dislocated laterally. An osteochondral defect (4 mm wide by 5 mm deep) was created, in the weight-bearing area of the internal femoral condyle (Kyphon® manual drill). The defect was accurately rinsed with a sterile physiological saline (NaCl 0.9% w/v). 5 μL of an alginate solution (2% in PBS) were gelled directly into each defect by the addition of 5 μL of a calcium chloride solution (2 mM in AcH 50 mM), giving a construct perfectly inserted and adherent to the subchondral bone and to the cartilaginous border. After gelation, the dislocation of patella was reduced and the knee joint was sutured in layers. When used, Stromal cells (1x10 6 cells/defect) and BMPs (15 μg/defect) were added as described (see "Preparation of alginate gels" section).
For 7 days after surgery, animals received daily 250 mg of cephazolin. Rabbits were kept in separate cages and were allowed to move freely. At 12 weeks post-surgery, animals were euthanized by intravenous injection of 100 mg/kg of sodium pentobarbital. Knee joints were exposed, samples were harvested, images were obtained and samples were fixed in 4% formalin.
Histology
For histological evaluation specimens were decalcified with 10% and 5% nitric acid for 3 and 2 days, respectively. Samples were paraffin embedded and then 4μm thick sections were cut from the paraffin blocks. Different histochemical stainings were carried out (Hyllested et al., 2002) Treatment groups and nomenclature 2 untreated knees were used as Standard of osteocartilage tissue (S); 6 were the Empty control defects (E); 7 defects were filled with Alginate gel alone (A); 5 defects with Alginate containing Cells (AC); 6 defects with Alginate and rhBMP-2 (A2); 6 defects with Alginate and rhBMP-4 (A4); 6 defects with composites Alginate-rhBMP-2 and Cells (A2C) and; another 6 with Alginate-rhBMP-4 and Cells (A4C) . Finally 10 defects were filled with Alginate and both BMPs (A24). Fig. 1A shows the appearance of an alginate gelled in vitro. These gels were used for the immobilization of both growth factors (rhBMP-2, rhBMP-4) and stromal cells. Cell viability was checked with the LIVE/DEAD® assay and Fig. 1 shows micrographs of cell seeded alginate gels (AC), Alginate and rhBMP-2 gels (A2C), and alginate and rhBMP-4 gels (A4C), on the 7 th culture day. In all cases mainly viable cells were observed and few red fluorescence points, which correspond to nuclei of dead cells. Fig. 1 also shows the quantitative assays performed (alamarBlue® assay). They show that cells are viable in the alginate gels and in culture at least during 7 days. No differences were observed in cell viability due to the addition of any of the rhBMPs.
Results

In vitro study of the implantable material
In vivo study: Gross morphology study of the articular cartilage Fig. 2 shows the surgical procedure for osteochondral defect formation and subsequent alginate filling. 3 months after surgery, the synovial fluid and synovium of knee appeared normal in 56 joints (note that 2 samples corresponding to the AC treatment were not included in the final study. They contained pus in both knees with a positive culture for Staphylococcus aureus). All filled defects (50 samples) had an opaque appearance and the surface was smooth and regular (Fig. 3) .
Histological study
Haematoxylin-eosin was used as non-specific staining to perform an initial quick morphological assessment (Fig.  4) . No tissue formation (empty space) could be observed in E treatment. In other treatments the defect is fully filled with newly formed tissue which means that alginate material disappears. Alginate treatment (A) shows fibrous tissue in the defect area with no bone regeneration (AC was similar, not shown). rhBMP-2 treatment (A2) and A2C show defect fully filled with bone tissue. In contrast, rhBMP-4 treatment (A4) shows poor subchondral bone formation and moderate cartilage regeneration in the defect area. A4C shows better subchondral bone formation and A24 shows both subchondral bone and cartilage regeneration, even if some fissures can be observed in newly formed cartilage. . This data suggests that the tissue formed in the defect area of these control groups corresponds to fibrillar tissue. In all other treatments these collagen fibres were not present (data not shown). 
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of these cells is disorganised, which correspond to fibrous tissue. rhBMP-2 treatment (A2) shows a defect fully filled with bone tissue, and similar histological appearance was observed in A2C treatment (not shown). In contrast, rhBMP-4 treatment (A4) shows poor subchondral bone formation which was highly vascularised (see arrowheads in figure 6), and also shows moderate cartilage regeneration (see arrows in figure 6) in the surface of the defect area. The addition of cells in the implanted structure (A4C) induced a hypercellularity in the defect area but no improvement in the tissue quality. Last image shows the appearance of an A24 filled defect. The knees of this treatment show complete subchondral bone regeneration with vascularised areas (see arrowheads) and also cartilage tissue regeneration (see arrows). The newly formed cartilage was similar in thickness to adjacent cartilage and looked bonded to it, even if some samples showed fissures and discontinuities in the surface. Fig. 7 also shows Masson´s trichrome staining. It shows higher magnification images of cartilage regeneration areas and different treatments. Fig. 8 shows Safranin O staining, which is a specific staining for cartilage proteoglycans. The first image shows the red staining corresponding to a control intact tissue (S). No proteoglycan staining was found in alginate A (AC not shown) and rhBMP-2 treatments A2 (A2C not shown). In contrast, all rhBMP-4 treatments show positive Safranin O staining. A4 treatment shows red staining deep inside the defect area suggesting poor bone tissue regeneration. A4C treatment shows highly positive stained surface with a clearly higher thickness than the adjacent cartilage. A24 treated knees show positive Safranin O staining and seems to be the most similar to the adjacent tissue and to the undamaged cartilage tissue. Fig. 9 corresponds to the performed toluidine blue staining, which is also a specific staining for cartilage proteoglycans (in this case blue staining, see figure 9S , undamaged cartilage tissue). The results obtained in this staining were quite similar to those ones obtained with Safranin O staining (Fig. 8) . A4C shows cell clusters, while A4, A4C and A24 show homogeneous staining and irregularities and fissures in the cartilage surface.
Histomorphometry
We observed sample volumetric shrinkage due to histological processing. Thus, the mean injury area was quantified in 9.8 mm 2 (±0.2 mm 2 ). According to it, the harvested bone and cartilage volumes were estimated in non-damaged knees (S) (Fig. 10A) . Fibrous tissue was the mainly observed one in Empty (E), Alginate (A) and Alginate/cells (AC) treatments (E: 2.3 mm 2 (±0.9 mm 2 ); ). Fig. 10 shows the measurements obtained for bone, cartilage and fibrocartilage tissues. These data quantified the high amount of bone in A2 and A2C and also the absence of cartilage tissue in them. Data also quantified cartilage formation in A4 and A4C. In this sense, the disparity in bone and fibrocartilage measurements observed in A4 samples is remarkable. In this A4 treatment, 4 samples show good bone formation, while 2 samples show high amount of fibrocartilage tissue with no bone regeneration.
Finally, data of A24 samples and non-damaged tissue (S) show no statistical differences in bone and cartilage values.
Discussion
Tissue engineering for osteochondral repair has received considerable attention in reconstructive surgery during the past decade. Most common strategies to engineer tissue involve the use of three components: growth factors, cells 
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and carrier scaffolds. In this study, alginate gels are used as carrier for stromal cells and also as carrier for rhBMP-2 and rhBMP-4 growth factors, in order to test this approach in rabbit osteochondral tissue regeneration and compare obtained data with previous in vitro and in vivo studies literature.
In vitro, several types of growth factors have been demonstrated to have chondrogenic activity whereas in vivo the most effective factors are those derived from the TGF superfamily (Van den Berg et al., 2001) . Specifically, rhBMP-2 and rhBMP-4 are promising candidates for the promotion of chondrogenesis due to their role in chondrocyte differentiation and matrix maturation (Luyten et al., 1994 , Miljkovic et al., 2008 . In vitro, rhBMP-2 and rhBMP-4 improved the cartilage tissue formation, both in BMP overexpressing cells (Weber et al., 2002; Gelse et al., 2003; Steinert et al., 2003; Steinert et al., 2009 ) and exogenously BMP stimulated cells (Kramer et al., 2000; Martin et al., 2001; Majumdar et al., 2001; Valcourt et al., 2002; Gründer et al., 2004 , Sekiya et al., 2005 . In vivo, osteochondral and endochondral tissue regeneration has been obtained with rhBMP-4 overexpressing cells (Kuroda et al., 2006a) and also with rhBMP-2 as exogenously administrated growth factor with collagen sponge (Sellers et al., 2000) and gelatine sponge (Tokuhara et al., 2009) as carrier materials.
With regard to the employment of cells, the chondrogenic differentiation of mesenchymal stem cells in vitro is well documented and also it has been previously demonstrated that these cells are able to generate cartilaginous tissue in vivo (Liu et al., 2003; Pelttari et al., 2008) . In this work bone marrow derived primary cell cultures are used, which have been successfully used in osteochondral tissue repair by other authors (Hannouche et al., 2007) . In these cultures most, but not all, of the cells are mesenchymal stem cells, being more similar to expected in vivo environment than highly purified stem cell cultures.
We used calcium alginate as carrier material for several reasons. First, alginate is a biocompatible polysaccharide that is structurally similar to glycosaminoglycans present in cartilage (Langer et al., 1993; Mierisch et al., 2003; Park et al., 2005) . Also, alginate gelation properties allow direct gel formation into the cartilaginous defects by simple addition of a calcium chloride solution. Thus, it is a fluid material that can fill any shape of defect and can incorporate various bioactive agents (e.g., Proteins and growth factors) (Gombotz et al., 1998; Tønnesen et al., 2002; Coviello et al. 2007; Lee et al., 2003) .
Alginate has been extensively reported for cartilage tissue regeneration purposes. However, Wang et al. (Wang et al., 2003) reported that in vitro raw alginate properties have influence in material properties and in the encapsulated cell proliferation and differentiation processes. These facts perhaps explain why some authors (Mierisch et al., 2003; Shao et al., 2006) reported no osteochondral tissue regeneration using alginate encapsulated MSCs, while using similar in vivo approach Fragonas et al. (Fragonas et al., 2000) show good osteochondral tissue regeneration, and Erickson et al. (Erickson et al., 2002) show ectopic cartilage formation.
Which regard to alginate and BMPs in cartilage repair, the enhancement of chondrogenic properties using alginate as carrier material has been reported in the following cases: rhBMP-2 stimulated MSCs (Majumdar et al., 2001) ; rhBMP-2 and rhBMP-4 overexpressing MSCs (Steinert et al., 2003) ; and rhBMP-2 stimulated chondrocytes (Gründer et al., 2004) .
With regard to the results obtained in this study, here we start with the performed control treatments. Figs. 4 and 5 show no defect filling and pannus formation in empty defects, and fibrous tissue formation in alginate treatment, which is in accordance with previous studies (Fragonas et al., 2000) . On the other hand, we observe a different behaviour due to rhBMP-4 or rhBMP-2 treatment. The histology shows hyaline cartilage tissue in the composites with rhBMP-4, which agrees with previous studies of the rhBMP-4 in experimental animals (Kuroda et al., 2006b; Miljkovic et al., 2008) . In these studies an improvement of the quality of the repaired tissue due to rhBMP-4 is reported. However we observe irregular amount of subchondral bone regeneration between A4 samples (compare A4 in all histological figures). This fact is reflected in the high standard deviation obtained in histomorphometrical study of A4 treatment (Fig. 10) . On the contrary, according to literature the composites with rhBMP-2 improved subchondral bone repair (Sellers et al., 2000; Tokuhara et al., 2009) , which is in agreement with our results. In our case, the histology shows that the treatment with rhBMP-2 and rhBMP-4 was the best of all tested approaches (see Fig. 10 ), with proper location and regeneration of subchondral bone and cartilage tissues.
With respect to the addition of stromal cells to alginate gel, previous in vivo assays performed with alginate gels and MSCs (the most similar than here presented ones) are once again contradictory: Fragona et al. show good osteochondral tissue regeneration while Mierisch et al. (Mierisch et al., 2003) show poor tissue regeneration. In our case, we firstly tested in vitro that cells were viable in the alginate gels in which would later be implanted (Fig.  1) . In vivo we observed that cell addition in alginate treatments had influence only in the behaviour of A4C composites, were cells induced the generation of more bone and cartilage than in A4 treatment. In fact A4C shows similar amount of bone between samples and high amount of both cartilage tissue and fibrocartilage tissue formation (see Fig. 10 ), which exceeds the upper limit of defect area. However, in order to clarify the role of implanted cells in the reparative procedure other resources (mainly in vivo trackable marked cells (Mierisch et al., 2003; Shao et al., 2006) should be used.
Conclusions
The results indicate that alginate gel may act as an appropriate delivery vehicle for growth factors and cells. It is a perfectly biocompatible carrier and presents advantages like its easy application and proper defect filling. With this carrier, we have observed a differential behaviour between the evaluated proteins, being rhBMP-2 superior in the restoration of the subchondral bone. In Y Lópiz- 
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contrast, higher efficiency of rhBMP-4 in the restitution of cartilage was observed. The data taken as a whole show the difficulties that still remain to restore a structure composed by two differentiated elements: bone and articular cartilage.
